Oncogenic Role of SET/I2PP2A for Gynecologic Cancers

Title:Oncogenic Role of SET/I2PP2A for Gynecologic Cancers

Volume: 18 Issue: 10

Author(s): Shi-wen Jiang, Siliang Xu, Haibin Chen, Jiayin Liu*Ping Duan

Affiliation:

• The State Key Laboratory of Reproductive Medicine, Center of Clinical Reproductive Medicine, First Affiliated Hospital of Nanjing Medical University, Nanjing Medical University, Nanjing 210029,China

Keywords: SET, PP2A, I2PP2A, INHAT, gynecologic cancer, steroid hormone, histone chaperone.

Abstract: SET (SE translocation, SET) is an evolutionarily conserved gene broadly expressed in various human tissues, especially in the gonadal and neural system. As a multitasking protein, SET is involved in essential cell processes such as histone modification, chromatin remodeling, DNA repair, gene transcription, and androgen synthesis. Recent studies showed that SET is overexpressed in breast cancers, ovary cancers and a variety of other malignancies. The strong correlation between SET expression levels and survival of ovarian cancer patients, and SET-mediated activation of androgen synthesis, strongly indicated that this factor may play a significant role in gynecologic cancers. Here, we summarized data pertaining to the pathological implications of SET in tumorigenesis and cancer progression. We analyzed how SET, through the PP2A-dependent and PP2A-independent pathways, may regulate different cell functions. Potential interactions among these pathways and future studies on SET’s oncogenic activities are also discussed.

Cite this article as:

Jiang Shi-wen , Xu Siliang, Chen Haibin, Liu Jiayin *, Duan Ping, Oncogenic Role of SET/I2PP2A for Gynecologic Cancers, Current Drug Targets 2017; 18 (10) . https://dx.doi.org/10.2174/1389450118666170328114506